Non‐glycaemic effects mediated via GLP‐1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide
Year: 2012
Type: review
Source: Diabetes Obesity and Metabolism
Authors: T. Vilsbøll, A. J. Garber
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Novo Nordisk, Novo Nordisk Fonden
Award: G2790715585
OpenAlex ID: W1970656852
